Clinical studies of SM-4300 in combination with antibiotics against severe bacterial infections
Otsuka, N.; Hiraoka, T.; Miyauchi, Y.; Hasegawa, Y.; Aratake, Y.; Furusho, N.; Kinoshita, A.; Mochinaga, M.; Yamaguchi, T.; Togami, K.
Japanese Journal of Antibiotics 38(9): 2673-2682
1985
ISSN/ISBN: 0368-2781 PMID: 4079032 Document Number: 248048
SM-4300, a newly developed human immunoglobulin preparation was evaluated in 24 patients with severe bacterial infections and the following results were obtained. The clinical efficacy was excellent in 4 cases, good in 7, fair in 5, poor in 3 and unknown in 5 with the effective rate of 57.9%. No serious side effect nor abnormalities in laboratory findings due to administration of SM-4300 were observed except 1 case with slight elevation of GOT and GPT.